NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell® will
be included in a new digital health initiative in over 500 Target®
stores nationwide beginning in April.
"We are delighted that Target will include Quell in their digital health
program," said Frank McGillin, SVP and General Manager, Consumer at
NeuroMetrix. "Consumer demand for innovative digital health solutions is
booming as shown in a recent study from Accenture reporting that 72% of
US consumers believe technology is important to managing their health.
Quell technology provides relief from chronic pain that is enhanced by
meaningful insight into therapy and sleep trends through its smartphone
app and the Quell Health Cloud.”
According to Mark P. Jones, Buyer - Target Health & Wellness, “To
further meet the health and wellness needs of our Guests, Target is
excited to offer connected health devices in select stores and at
Target.com, including Quell products, starting in spring 2016.”
Quell is FDA cleared and designed for millions of people suffering from
chronic pain. The latest version of Quell gives users the option to
start, stop, and adjust therapy discreetly via their smartphone. It also
enables advanced sleep tracking that provides feedback on eight
dimensions of sleep including sleep duration, quality, body position,
time out of bed, and repetitive leg movements throughout the night. In
addition to Target, Quell is available at select healthcare
professionals and retailers.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160317005256/en/
Copyright Business Wire 2016